Manage Your Liver
Q:

How to maximise results from YHK?

How to maximise results from YHK?
A:

YHK is a clinically proven liver therapy, research data shows that YHK can effectively lower ALT enzymes level and improve liver function within just 10-30 days without any side effects.

 

Having said that everyone might experience different levels of improvement, as each persons liver condition is different and YHK is not a type of chemical medicine, each individually will require different amount of YHK. In order to maximise the effects finding the right dosage is the key.

 

Insufficient dosage affect results

We have recently preformed a questionnaire with our YHK users, trying to get a better understand of their results with YHK comparing to the dosage they use. Results shows that all users who take 5-6 YHK tablets per day found to have ‘Obvious improvement’ in symptoms after using, with improved ALT levels.

 

There is more then 80% of users who take 3-4 tablets per day found to have ‘Obvious improvement’ or ‘Slight improvement’ in symptoms, also with improve ALT level. For users who take 1-2 tablets per day, over 50% has reported no obvious improvement in symptoms.

 

Recommended Dosage 

These results indicate that for people with abnormal liver function or those who have symptoms of liver problem, a higher dosage of YHK is recommended. Our recommendation is to use 6 YHK tablets per day for improvement in liver function.

 

A lower dosage of 3 YHK tablets per day is recommended for people who already have achieved normal liver function from YHK, and to use for maintaining normal function. This lower dosage is also suitable for people who does not have liver problems and are looking for liver protection only.

 

Your dosage is the best dosage

As we mentioned before, the key to achieve great results from YHK is to find the perfect dosage for yourself, monitoring changes in symptoms and using liver function test results as guidance will be the best tools to help you to identify the right dosage suitable for your condition.

 

If you experience little changes after using YHK, it is most likely that the dosage need to be increase, if you have any concerns or questions about the use of YHK, please contact our support team.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
YHK therapyYHK liverYHK cirrhosis treatmentYHKYHK effects
Related Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us